IR-MED is looking to raise a first round investment that will bring the company to:
- - Continue large scale clinical validation of the Propofol monitoring device
- - Complete clinical trials of the pressure ulcer program
- - Submit the pressure ulcer monitoring device to regulatory approvals (CE, FDA)
- - Prepare for large scale production of propriety medical devices
- September 2016
Support from Israeli innovation center at the ministry of commerce
IR-Med commenced its activity in early detection of pressure injuries , following a support grant from the innovation authority at the ministry of commerce.
- April 2017
IR-MED concluded its first stage of clinical trial in Non invasive monitoring of Propofol (sedation drug) .
- August 2017
IR-Med has commenced a clinical trial in a large Rehabilitation center in central of Israel to test its PressureSafe scanner, efficacy and safety for non invasive early detection of pressure injuries.